diabetes mellitus type 2
Conditions
Interventions
experimental group:Continuous glucose monitoring
Sponsors
the Second People's Hospital of Chizhou
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Patients with T2DM who met the 1999 WHO diagnostic criteria for diabetes mellitus; (2) Voluntary participation and ability to sign the subject informed consent before the trial; (3) Poor glycemic control prior to participation in this study; (4) Willingness to use CGM; (5) Voluntarily agreed to participate in this study by signing the informed consent form; (6) Age range: 18-80 years old.
Exclusion criteria
Exclusion criteria: (1) Patients with severe cardiopulmonary insufficiency (e.g., chronic obstructive pulmonary disease, stroke, heart failure, etc.) or severe abnormalities of liver and kidney function, or acute infections; (2) Patients with acute complications of diabetes mellitus (diabetic ketoacidosis, diabetic non-ketotic hyperosmolar coma, diabetic lactic acidosis, etc.); (3) Patients being treated with glucocorticoids and immunosuppressants; (4) Patients with a history of psychiatric system disorders that make them unsuitable for CGM use; (5) Other conditions (e.g., alcoholism, drug abuse, etc.) considered by the investigator to be unsuitable for participation in the study; (6) Patients with skin sensitization to the dynamic glucose monitoring sensor adhesive sheet.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| fasting blood glucose;2-hour postprandial blood glucose;glycosylated hemoglobin;time in target glucose range; | — |
Secondary
| Measure | Time frame |
|---|---|
| mean blood glucose;mean amplitude of glycemic excursion;standard deviation;time above range;time below range;Incidence of hypoglycemia; | — |
Countries
China
Contacts
Public ContactYiqi Xu
the Second People's Hospital of Chizhou
Outcome results
None listed